Immunovative Clinical Trials |
Immunovative has received Institutional review board approval for the following clincal trials: In Israel: Leukemia, Lymphoma and Multiple Myeloma NCT00558675. In Carlsbad: Leukemia, Lymphoma and Multiple Myeloma NCT00861965. In Carlsbad, CA: Metastatic cancer of any type with tumor in the liver or kidney or skin or lymph node or neck NCT00861107.
|
Hadassah is a world-class university medical institution and has achieved a global reputation for excellence in caring and curing though its innovative approach to complex medical problems and the cooperative efforts of the medical and research teams to provide individualized attention to individual problems.
Incorporating all medical and surgical sub-specialties, the Hadassah University Medical Center is a tertiary care referral facility, known for pioneering new medical techniques.
Patients with advanced hematological cancer or metastatic cancer that would like to be informed when protocols are approved should contact us at: